1.8  0 (0%)		12-12 16:00
Open: 1.8 High: 1.82 Volume: 533,528		Pre. Close: 1.8 Low: 1.7899 Market Cap: 133(M)

Short term
Mid term
Targets	6-month :	2.13	1-year :	2.49
Resists	First :	1.83	Second :	2.13
Pivot price	1.7
Supports	First :	1.41	Second :	1.15
MAs	MA(5) :	1.77	MA(20) :	1.66
	MA(100) :	1.18	MA(250) :	1.27
MACD	MACD :	0.1	Signal :	0.1
%K %D	K(14,3) :	92.3	D(3) :	92.7
RSI	RSI(14): 70.7
52-week	High :	1.89	Low :	0.81

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PLX ] has closed below upper band by 12.1%. Bollinger Bands are 4.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	1.82 - 1.83	1.83 - 1.84
Low:	1.77 - 1.78	1.78 - 1.79
Close:	1.78 - 1.8	1.8 - 1.81

"P"r"o"t"a"l"i"x" "B"i"o"T"h"e"r"a"p"e"u"t"i"c"s"," "I"n"c"."," "a" "b"i"o"p"h"a"r"m"a"c"e"u"t"i"c"a"l" "c"o"m"p"a"n"y"," "f"o"c"u"s"e"s" "o"n" "t"h"e" "d"e"v"e"l"o"p"m"e"n"t" "a"n"d" "c"o"m"m"e"r"c"i"a"l"i"z"a"t"i"o"n" "o"f" "r"e"c"o"m"b"i"n"a"n"t" "t"h"e"r"a"p"e"u"t"i"c" "p"r"o"t"e"i"n"s" "b"a"s"e"d" "o"n" "i"t"s" "p"r"o"p"r"i"e"t"a"r"y" "P"r"o"C"e"l"l"E"x" "p"l"a"n"t" "c"e"l"l"-"b"a"s"e"d" "p"r"o"t"e"i"n" "e"x"p"r"e"s"s"i"o"n" "s"y"s"t"e"m" "i"n" "t"h"e" "U"n"i"t"e"d" "S"t"a"t"e"s"," "A"u"s"t"r"a"l"i"a"," "C"a"n"a"d"a"," "I"s"r"a"e"l"," "B"r"a"z"i"l"," "R"u"s"s"i"a"," "T"u"r"k"e"y"," "a"n"d" "i"n"t"e"r"n"a"t"i"o"n"a"l"l"y"." "T"h"e" "c"o"m"p"a"n"y" "o"f"f"e"r"s" "E"l"e"l"y"s"o" "f"o"r" "t"h"e" "t"r"e"a"t"m"e"n"t" "o"f" "G"a"u"c"h"e"r" "d"i"s"e"a"s"e"." "I"t"s" "p"r"o"d"u"c"t" "p"i"p"e"l"i"n"e" "c"o"m"p"r"i"s"e"s" "P"R"X"-"1"0"2"," "a" "t"h"e"r"a"p"e"u"t"i"c" "p"r"o"t"e"i"n" "c"a"n"d"i"d"a"t"e"," "w"h"i"c"h" "i"s" "i"n" "t"h"e" "l"a"s"t" "s"t"a"g"e" "o"f" "c"l"i"n"i"c"a"l" "t"r"i"a"l"s" "f"o"r" "t"h"e" "t"r"e"a"t"m"e"n"t" "o"f" "F"a"b"r"y" "d"i"s"e"a"s"e"s";" "P"R"X"-"1"1"0"," "a" "p"r"o"p"r"i"e"t"a"r"y" "p"l"a"n"t" "c"e"l"l" "r"e"c"o"m"b"i"n"a"n"t" "f"o"r"m" "o"f" "h"u"m"a"n" "d"e"o"x"y"r"i"b"o"n"u"c"l"e"a"s"e" "I" "t"h"a"t" "h"a"s" "c"o"m"p"l"e"t"e"d" "p"h"a"s"e" "I"I"a" "c"l"i"n"i"c"a"l" "t"r"i"a"l"s" "f"o"r" "t"h"e" "t"r"e"a"t"m"e"n"t" "o"f" "c"y"s"t"i"c" "f"i"b"r"o"s"i"s";" "P"R"X"-"1"1"5"," "a" "p"l"a"n"t" "c"e"l"l"-"e"x"p"r"e"s"s"e"d" "r"e"c"o"m"b"i"n"a"n"t" "P"E"G"y"l"a"t"e"d" "U"r"i"c"a"s"e" "f"o"r" "t"h"e" "t"r"e"a"t"m"e"n"t" "o"f" "g"o"u"t";" "a"n"d" "P"R"X"-"1"1"9"," "a" "p"l"a"n"t" "c"e"l"l"-"e"x"p"r"e"s"s"e"d" "P"E"G"y"l"a"t"e"d" "r"e"c"o"m"b"i"n"a"n"t" "h"u"m"a"n" "D"N"a"s"e" "I" "p"r"o"d"u"c"t" "c"a"n"d"i"d"a"t"e" "f"o"r" "t"h"e" "t"r"e"a"t"m"e"n"t" "o"f" "N"E"T"s"-"r"e"l"a"t"e"d" "d"i"s"e"a"s"e"s"." "T"h"e" "c"o"m"p"a"n"y" "h"a"s" "a"g"r"e"e"m"e"n"t"s" "a"n"d" "p"a"r"t"n"e"r"s"h"i"p"s" "w"i"t"h" "P"f"i"z"e"r";" "F"u"n"d"a"ç"ã"o" "O"s"w"a"l"d"o" "C"r"u"z" "("F"i"o"c"r"u"z")";" "a"n"d" "C"h"i"e"s"i" "F"a"r"m"a"c"e"u"t"i"c"i" "S"."p"."A"." "T"h"e" "c"o"m"p"a"n"y" "w"a"s" "f"o"u"n"d"e"d" "i"n" "1"9"9"3" "a"n"d" "i"s" "b"a"s"e"d" "i"n" "H"a"c"k"e"n"s"a"c"k"," "N"e"w" "J"e"r"s"e"y".

Thu, 12 Dec 2024
Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - The Eastern Progress Online

Mon, 09 Dec 2024
Chiesi and Protalix Submit Game-Changing Monthly Dosing Regimen for Fabry Disease Treatment to EMA - StockTitan

Fri, 15 Nov 2024
Protalix BioTherapeutics Inc (PLX) Q3 2024 Earnings Call Highlights: Revenue Surge and ... - Yahoo Finance

Thu, 14 Nov 2024
Protalix: Q3 Earnings Snapshot - San Antonio Express-News

Thu, 14 Nov 2024
Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results - PR Newswire

Thu, 07 Nov 2024
Protalix BioTherapeutics Sets Q3 2024 Earnings Call for November 14 - StockTitan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: AMEX
Sector: Healthcare
Industry: Biotechnology
Shares Out	74 (M)
Shares Float	55 (M)
Held by Insiders	14.5 (%)
Held by Institutions	7.7 (%)
Shares Short	3,420 (K)
Shares Short P.Month	3,470 (K)

EPS	-0.24
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.38
Profit Margin	-38.7 %
Operating Margin	-18.1 %
Return on Assets (ttm)	-10.3 %
Return on Equity (ttm)	-43.5 %
Qtrly Rev. Growth	-61.6 %
Gross Profit (p.s.)	0
Sales Per Share	0.51
EBITDA (p.s.)	-0.19
Qtrly Earnings Growth	0 %
Operating Cash Flow	-3 (M)
Levered Free Cash Flow	1 (M)

PE Ratio	-7.83
PEG Ratio	2.1
Price to Book value	4.61
Price to Sales	3.47
Price to Cash Flow	-48.85

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.